Induction of Mixed Chimerism in Mice by Employing Different Conditioning Protocols and Bone Marrow Cell Transplantation

被引:7
|
作者
Baskiewicz-Masiuk, M. [1 ]
Grymula, K. [1 ]
Halasa, M. [1 ]
Pius, E. [1 ]
Boehlke, M. [2 ]
Machalinski, B. [1 ]
机构
[1] Pomeranian Med Univ, Dept Gen Pathol, PL-70111 Szczecin, Poland
[2] W Pomeranian Oncol Ctr, Szczecin, Poland
关键词
STEM-CELLS; TOLERANCE INDUCTION; MECHANISMS; SUBSETS;
D O I
10.1016/j.transproceed.2009.02.084
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mixed chimerism has been suggested to produce allograft tolerance. Since this phenomenon is not fully understood, the aim of our study was to evaluate various protocols for chimerism induction in a mouse model. B6.SJL-Ptprc(a)Pep3(b) mice were injected with 20 to 30 x 10(6) bone marrow cells from Balb C mice. Conditioning consisted of total body gamma irradiation with 9.5, 5, and 3 Gy on "-1 day" of the experiment, with 200 mg/kg cyclophosphamide (CP) ("+2 day"). Additionally, one group of mice received blocking antibody against CD40L on days 0, 1, 4, and 7. The presence of mixed chimerism in peripheral blood was assessed at 1, 2, 3, 4, 6, and 8 weeks using flow cytometry to detect CD45.1 or CD45.2 antigen expression. Moreover, the chimerism was examined in CD4, C138, CD45/B220, Mac-1 alpha subpopulations in peripheral blood and bone marrow cells at 8 weeks. We also compared chimerism in peripheral blood, bone marrow, and spleen leukocyte populations. We observed that the most effective conditioning method with relatively low toxicity was based on concomitant use of 5 Gy total body irradiation and CP. The percentage of donor cells differed among peripheral blood subpopulations and bone marrow cells, but was similar in leukocyte populations derived from various sources. Our experiments sought to optimize the induction of stable mixed chimerism.
引用
收藏
页码:1894 / 1899
页数:6
相关论文
共 50 条
  • [41] FISH detection of mixed chimerism in 33 patients submitted to bone marrow transplantation
    Palka, G
    Stuppia, L
    DiBartolomeo, P
    Morizio, E
    Peila, R
    Franchi, PG
    Calabrese, G
    BONE MARROW TRANSPLANTATION, 1996, 17 (02) : 231 - 236
  • [42] Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplantation
    Thiele, J
    Wickenhauser, C
    Kvasnicka, HM
    Varus, E
    Schneider, C
    Müller, H
    Beelen, DW
    ACTA HAEMATOLOGICA, 2003, 109 (04) : 176 - 183
  • [43] Non-genotoxic conditioning facilitates tolerance induction through stable mixed hematopoietic chimerism of gene modified bone marrow
    Hasan, M. A.
    Pettit, A. R.
    Steptoe, R. J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1481 - 1482
  • [44] Mixed chimerism of thyroid follicle cells after allogeneic bone marrow transplantation
    Thiele, J
    Varus, E
    Wickenhauser, C
    Kvasnicka, HM
    Weirauch, K
    Metz, KA
    Bellen, DW
    TRANSPLANTATION, 2003, 76 (10) : 1532 - 1533
  • [45] Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia
    Andreani, Marco
    Testi, Manuela
    Battarra, Mariarosa
    Indigeno, Paola
    Guagnano, Annalisa
    Polchi, Paola
    Federici, Giorgio
    Lucarelli, Guido
    BLOOD TRANSFUSION, 2008, 6 (03) : 143 - 149
  • [46] Induction of mixed chimerism and transplantation tolerance by portal vein injection of the allogeneic bone marrow or spleen cell without using sublethal radiation.
    Kim, JA
    Hong, SY
    Kim, DW
    Kim, CC
    BLOOD, 2000, 96 (11) : 302B - 302B
  • [47] MIXED CHIMERISM AFTER ALLOGENEIC MARROW TRANSPLANTATION
    FRASSONI, F
    CORVO, R
    STRADA, P
    SESSAREGO, M
    PIAGGIO, G
    FIGARI, O
    SCARPATI, D
    BACIGALUPO, A
    VITALE, V
    MICELI, S
    VANLINT, MT
    GUALANDI, F
    CLAVIO, M
    OCCHINI, D
    PITTALUGA, A
    MARMONT, A
    BONE MARROW TRANSPLANTATION, 1989, 4 : 241 - 243
  • [48] A cure for murine sickle cell disease (SCD) through stable mixed chimerism and tolerance induction after non-myeloablative conditioning and MHC-mismatched bone marrow transplantation.
    Kean, L
    Durham, M
    Adams, A
    Hsu, LL
    Waller, E
    Dillehay, D
    Pearson, T
    Larsen, C
    Archer, DR
    BLOOD, 2001, 98 (11) : 736A - 736A
  • [49] Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
    Andreani, Marco
    Testi, Manuela
    Gaziev, Javid
    Condello, Rossella
    Bontadini, Andrea
    Tazzari, Pier Luigi
    Ricci, Francesca
    De Felice, Lidia
    Agostini, Francesca
    Fraboni, Daniela
    Ferrari, Giuliana
    Battarra, Mariarosa
    Troiano, Maria
    Sodani, Pietro
    Lucarelli, Guido
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (01): : 128 - 133
  • [50] Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies
    Spitzer, TR
    McAfee, S
    Sackstein, R
    Colby, C
    Multani, P
    Saidman, S
    Weymouth, D
    Preffer, F
    Poliquin, C
    Foley, A
    Cox, B
    Andrews, D
    Sachs, DH
    Sykes, M
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (3A) : 309 - 320